Milestone Pharmaceuticals Inc. (MIST) › Shareholders' EquityMilestone Pharmaceuticals Inc. (MIST) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: $25.98M2018: $83.55M2019: $114.92M2020: $143.12M2021: $112.60M2022: $66.35M2023: $16.77M2024: $13.15M2025: $41.77M$41.77M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$41.77M+217.7%2024$13.15M-21.6%2023$16.77M-74.7%2022$66.35M-41.1%2021$112.60M-21.3%2020$143.12M+24.5%2019$114.92M+37.5%2018$83.55M+221.5%2017$25.98M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share